Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 11/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.43 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.32 |
| ▸ | FASN | P49327 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9556124 | 0.95 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM4EPOLB | |
| SCHEMBL9556120 | 0.95 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM4EPOLB | |
| SCHEMBL7782313 | 0.93 | CYP11B1 (0.39) | CYP11B1CYP11B2TRPV4KDM4E | |
| SCHEMBL10349795 | 0.92 | CYP11B1 (0.42) | CYP11B1CYP11B2TRPV4KDM4EKDM1A | |
| SCHEMBL10350015 | 0.91 | CYP11B1 (0.41) | CYP11B1CYP11B2TRPV4KDM4EKDM1A | |
| SCHEMBL10501859 | 0.90 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM1AFASN | |
| SCHEMBL10502378 | 0.90 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM1AFASN | |
| SCHEMBL10501185 | 0.90 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM1AFASN | |
| SCHEMBL10502810 | 0.89 | CYP11B1 (0.45) | CYP11B1CYP11B2TRPV4KDM1AEGLN2 | |
| SCHEMBL10768678 | 0.89 | CYP11B1 (0.40) | CYP11B1CYP11B2TRPV4KDM1AFASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0207975-B1 | LIQUID CRYSTALLINE PHASES | MERCK PATENT GmbH (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4818428-A | MIXTURE OF POLAR AND APOLAR COMPOUNDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-04-04 | — | — | US | disclosed |
| EP-0154840-B1 | LIQUID CRYSTAL COMPOUNDS | MERCK PATENT GmbH (DE) | 1989-01-25 | — | — | EP | disclosed |
| US-4784471-A | LIQUID CRYSTALS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-11-15 | — | — | US | disclosed |
| US-4704227-A | DERIVATIVES OF 1,3-DIOXANE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-11-03 | — | — | US | disclosed |
| EP-0211876-A1 | FLUOROBENZENE DERIVATIVES | MERCK PATENT GmbH (DE) | 1987-03-04 | — | — | EP | disclosed |
| EP-0207975-A1 | LIQUID CRYSTALLINE PHASES. | MERCK PATENT GMBH (DE) | 1987-01-14 | — | — | EP | disclosed |
| EP-0205503-A1 | LIQUID CRYSTALLINE PHASE. | MERCK PATENT GMBH (DE) | 1986-12-30 | — | — | EP | disclosed |
| WO-1986004895-A1 | FLUOROBENZENE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-08-28 | — | — | WO | disclosed |
| WO-1986004081-A1 | LIQUID CRYSTALLINE PHASES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-07-17 | — | — | WO | disclosed |
| WO-1986003769-A1 | LIQUID CRYSTALLINE PHASE | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-07-03 | — | — | WO | disclosed |
| EP-0154840-A2 | Liquid crystal compounds | MERCK PATENT GmbH (DE) | 1985-09-18 | — | — | EP | disclosed |